Clinical Trials Directory

Trials / Completed

CompletedNCT01010178

Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?

Combination of Approved Drug in COPD

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Baqiyatallah Medical Sciences University · Academic / Other
Sex
All
Age
22 Years – 86 Years
Healthy volunteers
Not accepted

Summary

Critical combination of various approved drugs in management for patients suffering with COPD.

Conditions

Interventions

TypeNameDescription
DRUGMacrolid, Theophylline, Inhaler Corticosteroidswe have no permission to include them in detail because of privacy policy of mentioned journal for publication

Timeline

Start date
2008-02-01
Primary completion
2009-04-01
Completion
2009-07-01
First posted
2009-11-09
Last updated
2009-11-09

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01010178. Inclusion in this directory is not an endorsement.